NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 148 filers reported holding NOVAVAX INC in Q4 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,000 | -68.2% | 12,000 | 0.0% | 0.00% | -75.0% |
| Q4 2018 | $22,000 | -4.3% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $23,000 | +43.8% | 12,000 | 0.0% | 0.01% | +33.3% |
| Q2 2018 | $16,000 | -36.0% | 12,000 | 0.0% | 0.01% | -33.3% |
| Q1 2018 | $25,000 | +66.7% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q4 2017 | $15,000 | +7.1% | 12,000 | 0.0% | 0.01% | +20.0% |
| Q3 2017 | $14,000 | 0.0% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $14,000 | -6.7% | 12,000 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $15,000 | 0.0% | 12,000 | 0.0% | 0.01% | +20.0% |
| Q4 2016 | $15,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |